Meceft S 250mg/125mg Injection
Marketer
Biobrick Pharma
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Meceft S 250mg/125mg Injection
Ceftazidime/Sulbactam 250mg/125mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting bacterial growth and preventing infection spread. Administration must always be under a doctor's direct supervision; strict adherence to the prescribed dosage schedule is crucial. Complete the entire course of treatment, even with symptom improvement; premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms to your physician immediately. Seek urgent medical attention for allergic reactions (skin rashes, itching, swelling, respiratory distress). Inform your doctor of all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor might order tests to monitor the treatment's effectiveness.
Uses of Meceft S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Meceft S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Meceft S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Meceft S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Meceft S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Meceft S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Meceft S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Cefuroxime 250mg/125mg injection is typically regarded as safe for use during gestation. Preclinical trials in animals revealed minimal or no harm to the fetus; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Meceft S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Nursing should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Cefuroxime injection (250mg/125mg) may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Meceft S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Administering Meceft S 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage changes for Meceft S 250mg/125mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Meceft S 250mg/125mg Injection :
Should you forget a dose of Meceft S 250mg/125mg Injection, seek your physician's advice.
Facts to Know About Meceft S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Anti-infective Agents |
3,018 People bought this recently